Literature DB >> 9598946

Risk factors and morbidity in patients with placenta previa accreta compared to placenta previa non-accreta.

Z M Zaki1, A M Bahar, M E Ali, H A Albar, M A Gerais.   

Abstract

BACKGROUND: Placenta accreta is associated with high morbidity and most cases occur with placenta previa. This study was carried out in an attempt to define risk factors for placenta accreta in cases of placenta previa and to quantify the increased morbidity of placenta previa accreta in comparison to placenta previa alone.
METHODS: The records of all patients delivered by cesarean section (CS) for placenta previa and accreta during the seven-year period from 1990 to 1996, inclusive, were reviewed. Data regarding the demographic features, previous CS, the incidence of hysterectomy and postpartum morbidity were analyzed.
RESULTS: Out of 23070 deliveries 110 (0.48%) had placenta previa, twelve (0.05%) of whom had placenta previa accreta. There was no significant difference in age and parity. Patients with a history of previous CS showed a significant increase in the incidence of placenta previa accreta (p=0.001). The percentage of accreta increased linearly from 4.1% in patients with no CS to 60% in patients who had had three or more CS. Postpartum hemorrhage and emergency hysterectomy were significantly higher among the previa accreta patients compared with the previa patients alone (p<0.001; p<0.001, respectively).
CONCLUSION: In the presence of a previous history of CS, patients with antepartum diagnosis of placenta previa are considered to be at a greater risk for having placenta accreta. The risk increases with the increase in the number of previous CS. Patients with placenta previa accreta have a significantly higher incidence of PPH and are more likely to undergo emergency hysterectomy.

Entities:  

Mesh:

Year:  1998        PMID: 9598946

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  10 in total

1.  Development of a scoring system to predict massive postpartum transfusion in placenta previa totalis.

Authors:  Jung-Won Kim; Yoon-Kyung Lee; Ji-Hyun Chin; Seon-Ok Kim; Mi-Young Lee; Hye-Sung Won; Woo-Jong Choi
Journal:  J Anesth       Date:  2017-05-02       Impact factor: 2.078

2.  Expectant and medical management of placenta increta in a primiparous woman presenting with postpartum haemorrhage: The role of Imaging.

Authors:  Papa Dasari; Bhuvaneswari Venkatesan; Chitra Thyagarajan; Sathyalakshmy Balan
Journal:  J Radiol Case Rep       Date:  2010-05-01

3.  Correlation of placental thickness and placenta percreta in patients with placenta previa: findings from MRI.

Authors:  Tao Lu; Yishuang Wang; Aiwen Guo; Yan Deng; Chengqian Wu; Xiangqi Li; Siyun Liu
Journal:  Abdom Radiol (NY)       Date:  2022-09-17

4.  Risk factors of neonatal anemia in placenta previa.

Authors:  Dong Gyu Jang; Yun Sung Jo; Sung Jong Lee; Gui Se Ra Lee
Journal:  Int J Med Sci       Date:  2011-09-19       Impact factor: 3.738

5.  Maternal outcomes according to placental position in placental previa.

Authors:  Dong Gyu Jang; Ji Sun We; Jae Un Shin; Yun Jin Choi; Hyun Sun Ko; In Yang Park; Jong Chul Shin
Journal:  Int J Med Sci       Date:  2011-07-23       Impact factor: 3.738

6.  Preservation of fertility and subsequent childbirth after methotrexate treatment of placenta percreta: a case report.

Authors:  Masato Tamate; Motoki Matsuura; Shutaro Habata; Yushi Akashi; Ryoichi Tanaka; Shinichi Ishioka; Toshiaki Endo; Tsuyoshi Saito
Journal:  J Med Case Rep       Date:  2015-10-19

7.  Factors associated with placenta praevia in primigravidas and its pregnancy outcome.

Authors:  Abdul Ghani Nur Azurah; Zakaria Wan Zainol; Pei Shan Lim; Mohd Nasir Shafiee; Nirmala Kampan; Wan Syahirah Mohsin; Norfilza Mohd Mokhtar; Muhammad Abdul Jamil Muhammad Yassin
Journal:  ScientificWorldJournal       Date:  2014-11-12

8.  Epidemiology of placenta previa accreta: a systematic review and meta-analysis.

Authors:  Eric Jauniaux; Lene Grønbeck; Catey Bunce; Jens Langhoff-Roos; Sally L Collins
Journal:  BMJ Open       Date:  2019-11-12       Impact factor: 2.692

9.  Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study.

Authors:  Kathryn E Fitzpatrick; Susan Sellers; Patsy Spark; Jennifer J Kurinczuk; Peter Brocklehurst; Marian Knight
Journal:  PLoS One       Date:  2012-12-27       Impact factor: 3.240

10.  Correlations from gadopentetate dimeglumine-enhanced magnetic resonance imaging after methotrexate chemotherapy for hemorrhagic placenta increta.

Authors:  Salim A Wehbe; Labib M Ghulmiyyah; Kenneth T Carroll; Mark Perloe; Daniel G Schwartzberg; E Scott Sills
Journal:  Biomagn Res Technol       Date:  2003-11-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.